BNC
Biotechnology, Next challenge CREATING A BETTER LIFE
Main History
2020
2020
- Acquired Export License for BIENOX (botulinum toxin)
- Completion of Sejong Pharmaceutical GM plant construction (expected date July, 2020)
- Completion of clinical trial phase 1 and 2 of botulinum toxin (expected time 3Q, 2020)
2019
2019
- KOSDAQ listing (at Korea Exchange)
- BIENOX IND approval and start of Clinical trial of phase 1,2
2018
2018
- Sejong Pharmaceutical Factory Groundbreaking Ceremony
- Most Trusted Brand Prize Winner (2016 Fortune Korea & CIBE Awards)
- Established China branch in China Dalian
- Awarded $ 5 Million Export Tower (55th Trade Day Festival ceremony, Korea International Trade Association)
2017
2017
- Awarded $ 3 Million Export Tower (54th Trade Day Festival ceremony, Korea International Trade Association)
- Inno-Biz feature : small but strong global company
- Collagen tissue supplement ‘Collapleo’ launch (KFDA approval)
2016
2016
- Awarded $ 1 Million Export Tower (53th Trade Day Festival ceremony, Korea International Trade Association)
- Excellent Business Management Prize (3rd Korea KONEX ceremony, KONEX)
- Korea Future Leader Power Brand Award Grand Prize (Sports Chosun)
- The 6th Consumer Loving Brand Awards, Filler Category 1st Place (Korean Chungang Daily Economist)
2015
2015
- Absorbable Collagen Wound Dressing ‘Genta Q’ Launch (KFDA approval)
- HA Dermal Filler with Lidocaine “Cutegel Lidocaine” Launch (KFDA approval)
- KONEX listing (at Korea New Exchange)
2014
2014
- Acquired ISO 9001, ISO 14001 certificates
- Daegu City Star Company Selection
- ASPA 2014 award Grand Prize
- Daegu 2014 creative economics ceremony Bronze Prize
- Daegu Techno Park Outstanding Company Selection
2013
2013
- HA Anti-adhesion barrier ‘Hibarry’ Launch
- Patent registration for Hyaluronic-acid Derivative particle and equipment manufacturing technique
- Acquired item licensing for Hibarry according to GMP for Medical Device (KFDA)
- Acquired CE Certificate / ISO 13485
2012
2012
- Dermal HA Filler ‘Cutegel’ Launch
- Acquired item licensing for Cutegel according to GMP for Medical Device (KFDA)
- HQ and research lab expansion, move from Hwaseong City to Daegu
- Acquired CE certificate and ISO 13484 for Cutegel
2011
2011
- Obtained an item approval for Wrinkle-improving Filler (KMFDS)
- Published a research article about Effect of Anti-adhesion agent (Journal of Veterninary Clinics)
2009
2009
- Certified as a Venture Company
2008
2008
- Approved as a medical device manufacturer that meets quality management standards
- Permitted as a Medical Device manufacturing company (KFDA)
2007
2007
- Establishment of BNC Korea, Inc.